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Abstract
Background:  MicroRNAs (miRNAs) have critical functions in various biological processes.
MiRNA profiling is an important tool for the identification of differentially expressed miRNAs in
normal cellular and disease processes. A technical challenge remains for high-throughput miRNA
expression analysis as the number of miRNAs continues to increase with in silico prediction and
experimental verification. Our study critically evaluated the performance of a novel miRNA
expression profiling approach, quantitative RT-PCR array (qPCR-array), compared to miRNA
detection with oligonucleotide microchip (microarray).
Results: High reproducibility with qPCR-array was demonstrated by comparing replicate results
from the same RNA sample. Pre-amplification of the miRNA cDNA improved sensitivity of the
qPCR-array and increased the number of detectable miRNAs. Furthermore, the relative expression
levels of miRNAs were maintained after pre-amplification. When the performance of qPCR-array
and microarrays were compared using different aliquots of the same RNA, a low correlation
between the two methods (r = -0.443) indicated considerable variability between the two assay
platforms. Higher variation between replicates was observed in miRNAs with low expression in
both assays. Finally, a higher false positive rate of differential miRNA expression was observed using
the microarray compared to the qPCR-array.
Conclusion: Our studies demonstrated high reproducibility of TaqMan qPCR-array. Comparison
between different reverse transcription reactions and qPCR-arrays performed on different days
indicated that reverse transcription reactions did not introduce significant variation in the results.
The use of cDNA pre-amplification increased the sensitivity of miRNA detection. Although there
was variability associated with pre-amplification in low abundance miRNAs, the latter did not
involve any systemic bias in the estimation of miRNA expression. Comparison between microarray
and qPCR-array indicated superior sensitivity and specificity of qPCR-array.
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Background
MicroRNAs (miRNAs) are small noncoding RNAs of 20-
22 nucleotides in length that direct posttranscriptional
regulation through specific recognition of short sequences
of target mRNAs, often in the 3' untranslated region,
reviewed in [1-3]. With >200 members per species in
higher eukaryotes, miRNAs are one of the largest gene
families, accounting for ~1% of the genome [4]. Multiple
studies have demonstrated that miRNAs are involved in
numerous integral biological processes including devel-
opment, cell proliferation, differentiation and apoptosis,
reviewed in [5,6]. The complex and dynamic expression
profiles of miRNA reflect the important roles in the con-
trol of mammalian growth and development. In fact,
miRNA expression studies have demonstrated that aber-
rant expression of miRNAs is causally related to a variety
of disease states such as cancer, diabetes, and heart failure
[7-10]. As the number of miRNAs continues to increase
with  in silico prediction and experimental verification,
miRNA profiling remains an important tool for identifica-
tion of differential expression of miRNAs in normal and
pathophysiologic processes.
Three main techniques have been used to detect and
quantify miRNA including cloning, hybridization with
selective probes, and polymerase chain reaction (PCR)-
based detection, reviewed in [11]. Cloning strategies iden-
tified many of the initial miRNAs and revealed that miR-
NAs are present in many species [12-14]. Hybridization
techniques include Northern blotting [15,16], bead-based
flow-cytometry [17], and oligonucleotide microchip
(microarray) [10,18,19]. While Northern Blotting using
radioactive probes is very sensitive, disadvantages of
Northern Blotting and cloning techniques are that both
are time-consuming and impractical for large scale detec-
tion of hundreds of miRNAs. Microarrays have been
widely used in miRNA profiling and can simultaneously
determine expression levels for large numbers of miRNAs
in a single experiment. However, the short length of miR-
NAs with inherently different melting temperatures (Tm)
and the highly similar sequences between miRNA family
members make probe design more difficult than for
mRNA arrays [20,21]. Although the development of
chemically modified probe design, such as Locked nucleic
acid (LNA) and 2'-O-(2-methoxyethyl)-(MOE) can ele-
vate Tm and stabilize hybridization [22,23], synthesis and
chemical modification of RNA probes can be costly. While
potentially providing more specific signals than microar-
ray, bead-based flow cytometric miRNA profiling meth-
ods require the removal of genomic DNA, followed by
recovery of small RNA fragments [17]; these multiple
steps have the potential to alter the miRNAs present in the
original sample. Furthermore, large quantities of RNA are
needed for hybridization techniques, which limit their use
in samples that yield small amounts of RNA. PCR-based
techniques are able to detect low copy numbers of indi-
vidual miRNAs with high sensitivity and specificity on
both the precursor [24,25] and the mature form of miR-
NAs [26]. The stem-loop reverse transcription- polymer-
ase chain reaction (RT-PCR) can profile miRNA
expression with only nanograms of total RNA or even sin-
gle cells [26-28]. Recently a quantitative RT-PCR based
array method (qPCR-array) became available which com-
bined the high sensitivity provided by the stem-loop RT-
PCR with the ability to profile large numbers of miRNA in
a single experiment [29].
The current study critically evaluated the reproducibility
of qPCR-array analyses using multiple aliquots of the
same RNA sample obtained from proliferating murine
myoblast cells to determine the intra- and inter-assay
reproducibility. The effect of pre-amplification on qPCR-
array reproducibility and sensitivity was also evaluated.
Finally, false positive rates of differential miRNA expres-
sion were compared to the microarray technique.
Methods
Cell culture and RNA isolation
Mouse C2C12 myoblasts [American Type Culture Collec-
tion (ATCC), Manassas, VA] were cultured in growth
media containing Dulbecco's Modified Eagle Medium
(DMEM) (ATCC), supplemented with 10% fetal bovine
serum (FBS) (Hyclone, Logan, UT) and 1% penicillin-
streptomycin (Mediatech, Inc., Herndon VA) at 37°C in a
humidified atmosphere of 5% CO2 in air. Total RNA was
isolated from proliferating C2C12 cells using TRIzol (Inv-
itrogen, Carlsbad, CA) according to manufacturer's
instructions. Total RNA concentration was quantified by
absorbance at 260 nm using a SmartSpec 3000 spectro-
photometer (Bio-Rad, Hercules, CA). RNA integrity was
assessed using the Agilent 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA) and samples with RNA
integrity number (RIN) >9 were used in the array studies.
Aliquots of the same RNA sample were used for all the
experiments in both the microarray and qPCR-array meas-
urements.
TaqMan Real-time PCR microRNA Array
The stem-loop RT-PCR based TaqMan Rodent MicroRNA
Arrays (Applied Biosystems, Foster City, CA) were used
representing 585 mature miRNA present in the Sanger
miRBase v12 in a two-card set of arrays (Array A and B).
Each array contains six positive controls and one negative
control. Array A focused on more highly characterized
miRNAs, while Array B contains many of the more
recently discovered miRNAs along with the miR*
sequences. RT-PCR reactions were performed according to
the manufacturer's instructions. All reagents were
obtained from Applied Biosystems. Briefly, 500 ng of total
RNA obtained from proliferating C2C12 cells was reverse-BMC Genomics 2009, 10:407 http://www.biomedcentral.com/1471-2164/10/407
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transcribed using Megaplex RT Primers and the TaqMan
miRNA reverse transcription kit in a total of 7.5 μl vol-
ume. Quantitative real-time PCR was performed using
Applied Biosystems 7900HT system and a TaqMan Uni-
versal PCR Master Mix with 6 μl cDNA input per plate.
Cycle threshold (Ct) values were calculated using the SDS
software v.2.3 using automatic baseline settings and a
threshold of 0.2. Since a Ct value of 35 represents single
molecule template detection, Ct values > 35 were consid-
ered to be below the detection level of the assay [30].
Therefore, only the miRNAs with a Ct ≤ 35 were included
in the analyses. PCR efficiency (E) was calculated accord-
ing to the formula: E = 10-1/slope, as previously described
[31]. The Ct value of an endogenous control gene
(MammU6) was subtracted from the corresponding Ct
value for the target gene resulting in the ΔCt value which
was used for relative quantification of miRNA expression.
As there is an inverse correlation between ΔCt and miRNA
expression level, lower ΔCt values were associated with
increased miRNA expression.
Pre-amplification of miRNA cDNA
For pre-amplification, 150 ng of total C2C12 RNA was
reverse-transcribed and the product (2.5 μl) was pre-
amplified using Megaplex PreAmp Primers and TaqMan
PreAmp Master Mix (Applied Biosystems) in a 25 μl PCR
reaction. The pre-amplification cycling conditions were
95°C for 10 min, 55°C for 2 min and 75°C for 2 min fol-
lowed by 12 cycles of 95°C for 15 sec and 60°C for 4 min.
The pre-amplified cDNA was diluted with 0.1× TE (pH
8.0) to 100 μl and then 10 μl diluted cDNA was used in
each plate for real-time PCR reactions.
MiRNA microarray analysis
The miRNA microarray analysis was performed by LC Sci-
ences (Houston, TX) using two replicate aliquots of the
C2C12 RNA. Briefly, the assay started with 8 μg of total
RNA. After size fractionation of the RNAs using a YM-100
Microcon centrifugal filter from Millipore, poly(A) tails
were added to RNA sequences with lengths less than 300
nucleotides using poly(A) polymerase. An oligonucle-
otide tag was ligated to the poly(A) tail for later fluores-
cent dye staining. RNA samples were hybridized overnight
on a μParaflo microfluidic chip using a micro-circulation
pump developed by Atactic Technologies [32]. Each
microfluidic chip contained the following probes: 1)
detection probes which consisted of chemically-modified
nucleotide sequences complementary to 617 mouse
mature miRNAs listed in the Sanger miRBase Release
12.0; 2) a total of 49 positive and negative control probes
designed by LC Sciences to determine uniformity of sam-
ple labeling and assay conditions and 3) a spacer segment
of polyethylene glycol to extend the coding segment away
from the substrate. The probes were made in situ using
photogenerated reagent chemistry. The hybridization
melting temperatures were balanced by chemical modifi-
cations of the probes. Hybridization reactions were per-
formed in 100 μl 6×SSPE buffer (0.90 M Sodium
Chloride, 60 mM Sodium Hydrogen Phosphate, 6 mM
EDTA, pH 6.8) containing 25% formamide at 34°C. After
RNA hybridization, tag-conjugating Cy3 dyes (one-color
hybridization) were circulated to samples for dye staining.
Each analyzed miRNA was repeated five times. A GenePix
4000B (Molecular Device, Union City, CA) laser scanner
was used to collect the fluorescence images which were
digitized using Array-Pro image analysis software (Media
Cybernetics, Bethesda, MD).
Data analysis
MiRNA microarray data were analyzed by LC Sciences by
subtracting the background and normalizing the signals
using a Locally-weighted Regression filter by 5S rRNA, as
described previously [33]. A miRNA was listed as detecta-
ble when it met at least three criteria: 1) signal intensity
higher than 3× the background standard deviation, 2)
spot coefficient of variation (CV) < 0.5, in which CV was
calculated as (standard deviation)/(signal intensity), and
3) at least 50% of the repeated probes had a signal 3-times
higher than background standard deviation. The miRNA
microarray data used the total gene signal, which was pro-
portional to the total number of targets bound by the
probes targeting each miRNA. Differentially expressed sig-
nals were determine by t-test with p < 0.01. To compare
qPCR-array and microarray assays, the log2 of microarray
signals was used.
Differential expression of miRNA measured by the qPCR-
array was tested using the Welch t-test. A p value < 0.01
was considered significant. Fisher's Z transformation was
used to test the equivalence of correlations [34]. The
power calculation was performed assuming unequal vari-
ances with estimates of the standard deviation based upon
all replicates in the experiment; estimates for the standard
deviations were on the log2 scale and included miRNAs
that had Ct values of ≤35. The PROC POWER function in
SAS 9.1 (Cary, NC) was used for this calculation. The Type
I (false positive error) error rate was chosen conservatively
as <0.0005 so that a Bonferroni adjustment for 100
hypotheses would achieve a family-wise error rate of 0.05.
Both miRNA microarray and qPCR-array data were sub-
mitted to the Gene Expression Omnibus (GEO; http://
www.ncbi.nlm.nih.gov/geo) in minimum information
about a microarray experiment (MIAME) compliant for-
mat with the series accession number GSE16000.
Results
Reproducibility of qPCR-array
Many in vitro handling steps are required for array analy-
ses and each processing step has the potential to generateBMC Genomics 2009, 10:407 http://www.biomedcentral.com/1471-2164/10/407
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variability in the data. Replicate preparations using differ-
ent aliquots of a single C2C12 RNA sample (500 ng) were
used to determine the reproducibility of the reverse tran-
scription process as well as the results of the same reverse
transcription products performed on different days. Taq-
Man Array A, which quantifies 375 of the most highly
characterized rodent miRNAs, was used. To evaluate the
reproducibility of reverse transcription and PCR reactions,
different aliquots of the same RNA were used for two sep-
arate reverse transcription reactions, and the products of
each reaction were used in two separate assays on two sep-
arate days for a total of 4 assays (Figure 1A). 47% of the
miRNAs had average Ct values ≤35 (see Additional file 1).
The raw Ct values of detectable miRNAs (miRNAs with Ct
≤35) were compared between each replicate for a total of
4 conditions. The comparison for every two replicates
demonstrated strong correlation with an average correla-
tion coefficient 0.978 (Figure 1B-E). The correlation for
each replicate set was significant (p < 0.0001) which indi-
cated a high degree of reproducibility. The slope of the lin-
ear trendline fitted along the correlation plot was nearly
equal to 1 in each comparison. The correlation coefficient
between replicates from the same or different reverse tran-
scription reactions were similar suggesting that different
reverse transcription reactions did not introduce signifi-
cant variation. Similar results were obtained when ΔCt
values were used for the comparison (data not shown).
PCR amplification efficiency was determined using a
series of different C2C12 RNA concentrations (5000 ng,
500 ng, or 50 ng). PCR efficiency for miRNAs with Ct ≤ 35
(n = 87) ranged between 2.22 and 1.80 with an average
efficiency of 1.94 ± 0.09.
An important consideration in experimental design is
determining the number of samples needed to provide
statistically valid results. Power calculations using the
above data indicated that at least four replicates are
needed to obtain >90% power with a Type I error rate of
<0.0005 to detect a fold change of 2 or 4 given the
observed standard deviations (Std Dev) (Table 1).
Reproducibility and Reliability of qPCR-array with pre-
amplification
Pre-amplification could potentially bias the expression of
miRNA transcripts. Therefore, it was important to deter-
mine if the relative expression of miRNAs in the original
cell population was uniformly maintained after pre-
amplification. To assess the reliability of pre-amplifica-
tion, miRNA expression profiles obtained with and with-
out pre-amplification using MiRNA TaqMan Array B,
which contains 210 recently discovered miRNAs along
with minor miR* sequences, were compared [35]. Differ-
ent aliquots of the same C2C12 RNA (150 ng) were used
in the reverse transcription and pre-amplification reac-
tions, both in duplicate (Figure 2A). The raw Ct values of
detectable miRNAs measured in each replicate qPCR-array
were highly correlated (Figure 2B and 2C). The Pearson's
correlation coefficients for each replicate qPCR-array pair
comparison was 0.985 and 0.990 for qPCR-arrays without
and with pre-amplification, respectively. To evaluate if
pre-amplification introduced bias to the original miRNA
expression levels, ΔCt values were compared between
amplified and non-amplified miRNAs and displayed on
the correlation plot in Figure 2D. Only miRNAs with a Ct
≤ 35 in samples without pre-amplification were included
and the calculated correlation was 0.924. A paired t-test
was used to test the null hypothesis of zero-difference in
the means and demonstrated that there was no observed
systematic bias in the estimation of the miRNA expression
levels (t = -0.63, p = 0.26). Therefore, miRNA quantifica-
tion using pre-amplification resulted in relative miRNA
expression levels that represented the level in the cell pop-
ulation without pre-amplification.
Specific miRNA pre-amplification uniformity was meas-
ured by calculating the ΔCt from all miRNAs with Ct ≤ 35
and determining the ΔΔCt between amplified (Amp) and
non-amplified reverse transcription (RT) targets (ΔΔCt =
|ΔCtAmp-ΔCtRT|). ΔΔCt values near zero therefore indicate
pre-amplification uniformity. Targets that produce ΔΔCt
values within ± 1.5 were considered uniformly preampli-
fied (TaqMan PreAmp Master Mix Protocol, Applied Bio-
systems). Using this approach, 85% miRNAs displayed
ΔΔCt < 1.2 (Figure 2E). When the Ct was ≤ 30, 95% of all
miRNAs had a ΔΔCt < 1.2.
To assess the efficiency of pre-amplification, the number
of detectable miRNAs with Ct ≤ 35 in each replicate of
both qPCR-arrays with and without pre-amplification was
estimated. The average Ct values of detectable miRNAs in
amplified samples were plotted against those obtained
from samples that were not pre-amplified (Figure 2F). The
number of detectable miRNAs was almost two-fold higher
in pre-amplified samples (115/216, 53%) compared to
samples without pre-amplification (66/216, 31%). All
miRNAs detected in non-amplified samples were also
detected in samples with pre-amplification. This differ-
ence demonstrates the increased sensitivity of pre-ampli-
fication prior to qPCR-array analysis. The Ct values of the
miRNAs only detected by pre-amplification showed
higher reproducibility for the pre-amplified samples com-
pared to samples that were not pre-amplified (r = 0.991
vs. r = 0.441; p < 0.0001) (Figure 2G and 2H). This dem-
onstrates that pre-amplification improved not only the
number of miRNAs that were detectable (Ct ≤ 35), but
pre-amplification also increased the reliability of these
miRNA measurements. Since PCR products double with
each amplification cycle, a 12-cycle pre-amplification willBMC Genomics 2009, 10:407 http://www.biomedcentral.com/1471-2164/10/407
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Experimental design and reproducibility of qPCR-array Figure 1
Experimental design and reproducibility of qPCR-array. A, The same RNA (500 ng) was used in two different reverse 
transcription (RT) reactions and the products were used in qPCR-arrays performed on different days. B and C, inter-assay 
reproducibility as determined by comparison of raw Ct values between replicates of different day reactions. D and E, inter-
sample reproducibility as determined by comparison of raw Ct values between replicates of different RT reactions. Corre-
sponding r and p values were determined by linear regression analysis. Sample number presented in each plot.
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result in 12 cycles of Ct shift, or a 212 = 4096-fold change.
Because the cDNA was diluted by 24 times in the pre-
amplified samples compared to samples without pre-
amplification, theoretically, this allowed a 4096/24 =
171-fold difference of input between amplified and non-
amplified samples or a decrement of 7.4 cycles of Ct.
There were 7.6 ± 1.5 (mean ± Std Dev, n = 115) cycles dec-
rement with the Ct value of the detectable miRNAs in
samples with pre-amplification, indicating almost 100%
pre-amplification efficiency.
Comparison of qPCR-array and microarray assays
Microarray is one of the most popular technologies for
miRNA expression profiling [10,18,19]. The relationship
between results obtained with qPCR-array and microar-
rays was determined. Independent miRNA expression
profiling studies using uParaflo microfluidic biochips
were performed by an independent company [36]. Aliq-
uots of the same C2C12 RNA were used in both the qPCR-
array (500 ng) and microarrays (8 μg). Comparison of
miRNA expression level in duplicate samples for microar-
ray analysis indicated good reproducibility (r = 0.974; Fig-
ure 3A). Since pre-amplification was not used in
microarray assays, miRNA expression levels in microarray
were compared to those in miRNA TaqMan Array A with-
out pre-amplification; 84 miRNAs were detected in both
microarray and qPCR-array (Ct ≤ 35). The results of both
assays were compared by plotting the ΔCt values of qPCR-
array versus the log2 of the microarray signal for each
miRNA (Figure 3B). An inverse correlation should exist
between the two methods since increasing miRNA expres-
sion was associated with decreasing ΔCt values in qPCR-
array and increasing log2 signal in the microarray assay.
The calculated correlation was -0.443. Although signifi-
cant (p < 0.0001), this correlation indicated considerable
variation in the results associated with the separate analy-
sis platforms. To determine which miRNAs displayed the
highest degree of variation for the two platforms, GC con-
tent and miRNA expression level were evaluated for each
mature miRNA (Table 2). There were no significant differ-
ences in correlation coefficients when the detected miR-
NAs were divided into three groups based on GC content.
However, individual correlation coefficients for subsets
based on Ct value indicated a much higher variation
between the two platforms for the low abundant miRNAs
(Ct > 30) compared to the moderately (Ct between 25-30)
and highly (Ct ≤ 25) expressed miRNAs.
To further compare the performance of qPCR-array and
microarray, the expression levels for each miRNA in each
replicate of the two platforms were compared. False posi-
tivity was defined as detection of significant differential
expression of miRNAs between replicates in qPCR-array
and microarrays. In-depth microarray data analyses were
performed by the company and revealed 48 out of 382
miRNAs (13%) with significant differential expression (p
< 0.01) between the aliquots of the same C2C12 RNA.
However, only 2 (miR-503, 322) out of 172 detectable
miRNAs (1%) were demonstrated to be significantly dif-
ferent (p < 0.01) between different reverse transcription
reactions in qPCR-array. These two miRNAs were not
detectable in the microarray assays (signal < 32). The 48
differentially expressed miRNAs in the microarray had a
wide range of expression levels, including 23 miRNAs
with signals >500 and 25 miRNAs with signal <500 (rang-
ing between 10 and 15000 with average 1601 ± 2767).
These results indicated that a low expression level was not
always responsible for the false positive differential
expression of miRNAs in the microarray analysis.
Discussion
Due to the superior sensitivity and specificity, qPCR has
been used as the "gold standard" to verify microarray
expression data. The availability of qPCR-arrays makes
this approach the method of choice for high-throughput
miRNA expression profiling. Consistent with the results
of Mestdagh et al. in profiling human miRNAs [29], our
results clearly demonstrated high reproducibility of
murine qPCR-array using RNA derived from C2C12 cells.
Although Mestdagh et al [29] suggested reverse transcrip-
tion reactions as a major factor contributing to the
observed variation, our comparisons between different
reverse transcription reactions with qPCR-arrays per-
formed on different days produced similar correlation
coefficients.
Table 1: Power Analysis of qPCR-array data derived from replicates of the same C2C12 RNA sample.
Fold Change Std Dev % miRNA* Type I Error Rate Actual Power Number Per Group
2 0.1 17% 0.00025 0.944 4
2 0.2 58% 0.00034 0.974 6
2 0.3 82% 0.00039 0.937 8
4 0.1 17% 0.00025 >.999 4
4 0.2 58% 0.00025 0.944 4
4 0.3 82% 0.00030 0.974 5
*Percent of miRNA in our sample with the stated power.BMC Genomics 2009, 10:407 http://www.biomedcentral.com/1471-2164/10/407
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Experimental design and comparison of miRNA expression between samples with and without pre-amplification Figure 2
Experimental design and comparison of miRNA expression between samples with and without pre-amplifica-
tion. A, The same RNA (150 ng) was used in the reverse transcription (RT) and pre-amplification reactions. B and C, correla-
tion plot between raw Ct values for each replicate with (Amp) or without (RT) pre-amplification. D, correlation plot of ΔCt 
obtained with and without pre-amplification. E, difference in miRNA expression (ΔΔCt) between amplified and non-amplified 
samples. ΔΔCt values were plotted as the average Ct of non-amplified samples. F, correlation plot between raw Ct values 
obtained with and without pre-amplification. Data points represented by white dots indicate miRNAs that were only detecta-
ble in pre-amplified samples. G and H, correlation plot of Ct values of miRNAs detected only in pre-amplified samples between 
replicates with and without pre-amplification. Corresponding r and p value determined by linear regression analysis and sample 
number presented in each plot.
A
total RNA of 
C2C12 cells 
(150 ng)
RT
RT1
RT2
qPCR with Amp (Amp1)
qPCR without Amp (RT1)
qPCR with Amp (Amp2)
qPCR without Amp (RT2)
BC
qPCR without Amp (RT2)
D E 6
|
1.2
2.4
3.6
4.8
t
=
 
|
ǻ
C
t
A
m
p
-
ǻ
C
t
R
T
|
F
0
15 20 25 30 35
Ct RT
ǻ
ǻ
C
30
35
p
10
15
20
25
10 15 20 25 30 35 40
A
v
g
 
C
t
 
A
m
p
G
30
35
40
A
m
p
2
30
35
40
T
2
H
10 15 20 25 30 35 40
Avg Ct RT
20
25
30
20 25 30 35 40
C
t
A
Ct Amp1
r = 0.911
p < 0.0001
n = 49
20
25
30
20 25 30 35 40
C
t
 
R
T
Ct RT1
r = 0.441
p = 0.0015
n = 49BMC Genomics 2009, 10:407 http://www.biomedcentral.com/1471-2164/10/407
Page 8 of 10
(page number not for citation purposes)
Pre-amplification has been used extensively for array anal-
ysis, especially when the RNA quantity is limited. By com-
paring miRNAs identified in samples with and without
pre-amplification, our results demonstrated that the
number of detectable miRNAs was almost twofold higher
in pre-amplified samples. This result was very reproduci-
ble even when large amounts of RNA (500 ng) were used
(Chen and Shireman, unpublished data). Thus, amplifica-
tion improved the sensitivity of the qPCR-array analysis,
enabling the identification of biologically regulated miR-
NAs that may have been below the detection level of the
qPCR-array if pre-amplification had not been used. Simi-
lar results have also been demonstrated with PCR ampli-
fication using mRNA templates [37,38]. A major concern
with using pre-amplification was the possibility that not
all miRNA transcripts would be uniformly amplified. Our
results suggested that relative miRNA expression levels
were maintained between samples with and without pre-
amplification. However, while most of the miRNAs
(85%) were uniformly pre-amplified, we did observe
increased variation associated with pre-amplification in
low abundant miRNAs. Although primer and probe
length/sequence could influence the pre-amplification
efficiency, miRNAs with low expression level and high Ct
values may also contribute to the variation. Similar uni-
formity of pre-amplification of miRNA has previously
been reported by Mestdagh et al [29] except the correla-
tion coefficient was decreased (r2 = 0.797) for miRNA
expression from amplified and non-amplified samples
compared to the current study (r2 = 0.854). Differing
amounts of initial RNA used for pre-amplification, 10 ng
(Mestdagh et al) versus 150 ng (current study) may
account for the increased correlation coefficient in the cur-
rent study. Therefore, the expression data for low abun-
dant miRNAs obtained by pre-amplification should be
interpreted with caution and confirmed in independent
experiments or biological replicates.
To facilitate the comparison of miRNA expression data
between different publications, it was important to deter-
mine the correlation between qPCR-arrays and microar-
rays. To our knowledge, this study is the first report with
extensive comparison of miRNA expression between
microarray and qPCR-array analysis. Even though the
same RNA samples were used in both microarray and
qPCR-array assays, a low correlation (r = -0.443) was
observed with miRNA expression indicating the variation
associated with the two platforms. Higher variation was
especially observed in low abundant miRNAs. Stem-loop
RT-PCR is highly sensitive and can detect an expression
range of at least 7 logs [26], while microarray platforms
can usually detect a 3-4 log of dynamic range [39,40].
Because the larger dynamic range imparts TaqMan qPCR-
array with superior detection sensitivity, the expression
variation observed in low abundant miRNA may reflect
the different sensitivities of the two platforms. Although
Ach et al [41] reported good correlations (r > 0.9) in 53/
60 miRNAs when comparing microarray (Agilent) and
individual TaqMan qPCR assays (Applied Biosystems),
they could not compare all 60 miRNAs in one plot
because qPCR and microarray assays have differential sen-
sitivities to different miRNAs. When comparing the
expression levels for each miRNA in each replicate of
microarray and qPCR-array, we also observed a higher
false positive rate of differential miRNA expression in the
microarray assay. The stem-loop primers allow discrimi-
nation between miRNAs that differ by only a single nucle-
otide [26]. While the development of chemically
modified probe design, such as Locked nucleic acid (LNA)
and 2'-O-(2-methoxyethyl)-(MOE) enables high-affinity
hybridizations to yield accurate miRNA detection [22,23],
the lower false positive rate observed in qPCR-array may
reflect its superior specificity compared to uParaflo micro-
fluidic biochips. Although several papers reported high-
resolution examination of the performance of microarrays
in detecting differential expression at different fold
changes [29,41], the results should be interpreted with
caution and verified by quantitative RT-PCR due to the
high rate of false positive results.
Conclusion
Our studies demonstrated high reproducibility of TaqMan
qPCR-array. Comparison between different reverse tran-
scription reactions and qPCR-arrays performed on differ-
Table 2: Comparison of miRNA expression between microarray and qPCR-array basedon GC content and Ct value
Number of miRNA Correlation coefficient p value*
GC contents (%) >30 to 45 25 -0.413
>45 to 55 41 -0.403
>55 18 -0.490 0.8988
Ct value >20 to 25 9 -0.709
>25 to 30 55 -0.428
>30 to 35 20 -0.108 0.0428†
*Test of equivalence of correlations.
†p value for >25 to 30 compared to >30 to 35, >20 to 25 excluded from test due to small sample size in group.BMC Genomics 2009, 10:407 http://www.biomedcentral.com/1471-2164/10/407
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ent days indicated that reverse transcription reactions did
not introduce significant variation. The use of cDNA pre-
amplification increased the sensitivity of miRNA detec-
tion. Although there were variations associated with pre-
amplification in low abundance miRNAs, the latter did
not involve any systemic bias in the estimation of miRNA
expression ratios. Comparison between microarray and
qPCR-array indicated superior sensitivity and specificity
of qPCR-array.
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